Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Research article

Safety classification of herbal medicines used in pregnancy in a multinational study

Authors: D. A. Kennedy, A. Lupattelli, G. Koren, H. Nordeng

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

The use of herbal medicines for health prevention and ailments is an increasing trend worldwide. Women in pregnancy are no exception; the reported prevalence of herbal medicine use in pregnancy ranges from 1 to 60 %. Despite a common perception of safety, herbal medicines may have potent pharmacological actions, and historically, have been used for this reason.

Methods

A multinational, cross-sectional study on how women treat disease and pregnancy-related health ailments was conducted between October 2011 and February 2012 in Europe, North America, and Australia. This study’s primary aim was to evaluate and classify the herbal medicines used according to their safety in pregnancy and, secondly, to investigate risk factors associated with the use of contraindicated herbal medicines during pregnancy.

Results

In total, 29.3 % of the women (n = 2673) reported the use of herbal medicines in pregnancy; of which we were able to identify 126 specific herbal medicines used by 2379 women (89.0 %). Twenty seven out of 126 herbal medicines were classified as contraindicated in pregnancy, and were used by 476 women (20.0 %). Twenty-eight were classified as safe for use in pregnancy and used by the largest number of women (n = 1128, 47.4 %). The greatest number was classified as requiring caution in pregnancy; these sixty herbal medicines were used by 751 women (31.6 %). Maternal factors associated with the use of contraindicated herbal medicines in pregnancy were found to be working in the home, having a university education, not using folic acid, and consuming alcohol. Interestingly, the recommendation to take a contraindicated herbal medicine was three times more likely to be from a healthcare practitioner (HCP) than an informal source.

Conclusion

Based on the current literature the majority of women in this study used an herbal medicine that was classified as safe for use in pregnancy. Women who reported taking a contraindicated herb were more likely to have been recommended it use by an HCP rather than informal source(s), indicating an urgent need for more education among HCPs. The paucity of human studies on herbal medicines safety in pregnancy stands in stark contrast to the widespread use of these products among pregnant women.
Appendix
Available only for authorised users
Literature
1.
2.
Hall HG, Griffiths DL, McKenna LG. The use of complementary and alternative medicine by pregnant women: a literature review. Midwifery. 2011;27(6):817–24.CrossRefPubMed
3.
Frawley J, Adams J, Sibbritt D, Steel A, Broom A, Gallois C. Prevalence and determinants of complementary and alternative medicine use during pregnancy: results from a nationally representative sample of australian pregnant women. Aust N Z J Obstet Gynaecol. 2013;53(4):347–52.CrossRefPubMed
4.
Holst L, Wright D, Haavik S, Nordeng H. Safety and efficacy of herbal remedies in obstetrics-review and clinical implications. Midwifery. 2011;27(1):80–6.CrossRefPubMed
5.
Nordeng H, Bayne K, Havnen GC, Paulsen BS. Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome. Complement Ther Clin Pract. 2011;17(3):147–51.CrossRefPubMed
6.
Lapi F, Vannacci A, Moschini M, Cipollini F, Morsuillo M, Gallo E, Banchelli G, Cecchi E, Di Pirro M, Giovannini MG, Cariglia MT, Gori L, Firenzuoli F, Mugelli A. Use, attitudes and knowledge of complementary and alternative drugs (cads) among pregnant women: a preliminary survey in Tuscany. Evid Based Complement Alternat Med. 2010;7(4):477–86.
7.
Moussally K, Oraichi D, Berard A. Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Saf. 2009;18(6):454–61.CrossRefPubMed
8.
Louik C, Gardiner P, Kelley K, Mitchell AA. Use of herbal treatments in pregnancy. Am J Obstet Gynecol. 2010;202(5):439.e431-439.e410.
9.
Holst L, Wright D, Nordeng H, Haavik S. Use of herbal preparations during pregnancy: focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich, UK. Complement Ther Clin Pract. 2009;15(4):225–9.CrossRefPubMed
10.
Nordeng H, Havnen GC. Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol Scand. 2005;84(1):26–33.CrossRefPubMed
11.
Pallivalappila AR, Stewart D, Shetty A, Pande B, McLay JS. Complementary and alternative medicines use during pregnancy: a systematic review of pregnant women and healthcare professional views and experiences. Evid Based Complement Alternat Med. 2013;2013:10.CrossRef
12.
Warriner S, Bryan K, Brown AM. Women’s attitude towards the use of complementary and alternative medicines (cam) in pregnancy. Midwifery. 2014;30(1):138–43.CrossRefPubMed
13.
Kennedy D, Lupattelli A, Koren G, Nordeng H. Herbal medicine use in pregnancy: results of a multinational study. BMC Complement Altern Med. 2013;13(1):355.CrossRefPubMedPubMedCentral
14.
Dante G, Bellei G, Neri I, Facchinetti F. Herbal therapies in pregnancy: What works? Curr Opin Obstet Gynecol. 2014;26(2):83–91.CrossRefPubMed
15.
Mills E, Duguoa J-J, Perri D, Koren G. Herbal medicines in pregnancy and lactation: An evidence-based approach. London ; New York: Taylor & Francis; 2006.CrossRef
16.
Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf. 2004;13(6):371–80.CrossRefPubMed
17.
18.
Mills SY, Bone K. The essential guide to herbal safety. St. Louis, Mo: Elsevier Churchill Livingstone; 2005.
19.
20.
Gardner ZE, McGuffin M, American Herbal Products Association. American herbal products association’s botanical safety handbook. 2nd ed. Boca Raton: American Herbal Products Association, CRC Press; 2013.
21.
Romm AJ. Botanical medicine for women’s health, vol. xix. St. Louis, Mo: Churchill Livingstone/Elsevier; 2010. p. 694.
22.
23.
Duke JA, Duke JA. Handbook of medicinal herbs. 2nd ed. Boca Raton, FL: CRC Press; 2002.CrossRef
24.
Gruenwald J, Brendler T, Jaenicke C. Pdr for herbal medicines. 4th ed. Montvale, NJ: Medical Economic Company; 2000.
25.
Hardin JW, Hilbe J. Generalized estimating equations. Boca Raton: CRC Press; 2013.
26.
Dante G, Pedrielli G, Annessi E, Facchinetti F. Herb remedies during pregnancy: a systematic review of controlled clinical trials. J Matern Fetal Neonatal Med. 2013;26(3):306–12.CrossRefPubMed
27.
Brinker F. Managing and interpreting the complexities of botanical research. HerbalGram. 2009;82:42–9.
28.
Venkataramanan R, Komoroski B, Strom S. In vitro and in vivo assessment of herb drug interactions. Life Sci. 2006;78(18):2105–15.CrossRefPubMed
29.
Committee on Herbal Medicinal Products. Community herbal monograph on plantago ovata forssk., semen. London: European Medicines Agency; 2013.
30.
Committee on Herbal Medicinal Products. Community herbal monograph on salix, cortex. London: European Medicines Agency; 2009.
31.
Holst L, Haavik S, Nordeng H. Raspberry leaf--should it be recommended to pregnant women? Complement Ther Clin Pract. 2009;15(4):204–8.CrossRefPubMed
32.
Jepson RG, Williams G, Johnathan C. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2008;(1):CD001321.
33.
Perez-Lopez FR, Haya J, Chedraui P. Vaccinium macrocarpon: an interesting option for women with recurrent urinary tract infections and other health benefits. J Obstet Gynaecol Res. 2009;35(4):630–9.CrossRefPubMed
34.
Wing DA, Rumney PJ, Preslicka CW, Chung JH. Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol. 2008;180(4):1367–72.CrossRefPubMedPubMedCentral
35.
Heitmann K, Nordeng H, Holst L. Pregnancy outcome after use of cranberry in pregnancy--the Norwegian mother and child cohort study. BMC Complement Altern Med. 2013;13:345.CrossRefPubMedPubMedCentral
36.
37.
Mills S, Bone K. Principles and practice of phytotherapy: Modern herbal medicine. Edinburgh, New York: Churchill Livingstone; 2000.
38.
Hoffmann D. Medical herbalism : The science and practice of herbal medicine. Rochester, Vt: Healing Arts Press; 2003.
39.
40.
O’Higgins A, Murphy OC, Egan A, Mullaney L, Sheehan S, Turner MJ. The use of digital media by women using the maternity services in a developed country. Ir Med J. 2014;107(10):313–5.PubMed
41.
Bert F, Gualano MR, Brusaferro S, De Vito E, de Waure C, La Torre G, Manzoli L, Messina G, Todros T, Torregrossa MV, Siliquini R. Pregnancy e-health: a multicenter Italian cross-sectional study on internet use and decision-making among pregnant women. J Epidemiol Community Health. 2013;67(12):1013–8.
42.
van Gelder MM, Bretveld RW, Roeleveld N. Web-based questionnaires: the future in epidemiology? Am J Epidemiol. 2010;172(11):1292–8.CrossRefPubMed
43.
Ekman A, Dickman PW, Klint A, Weiderpass E, Litton JE. Feasibility of using web-based questionnaires in large population-based epidemiological studies. Eur J Epidemiol. 2006;21(2):103–11.CrossRefPubMed
44.
Lupattelli A, Spigset O, Twigg MJ, Zagorodnikova K, Mardby AC, Moretti ME, Drozd M, Panchaud A, Hameen-Anttila K, Rieutord A, Gjergja Juraski R, Odalovic M, Kennedy D, Rudolf G, Juch H, Passier A, Bjornsdottir I, Nordeng H. Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open. 2014;4(2):e004365.
Metadata
Title
Safety classification of herbal medicines used in pregnancy in a multinational study
Authors
D. A. Kennedy
A. Lupattelli
G. Koren
H. Nordeng
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1079-z

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue

Research article

Antiproliferation of Cryptocarya concinna-derived cryptocaryone against oral cancer cells involving apoptosis, oxidative stress, and DNA damage

Research article

Pharmacological screening of Monotheca buxifolia (Falc.) A. DC. for antinociceptive, anti-inflammatory and antipyretic activities

Research article

Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses

Research article

Emu oil offers protection in Crohn’s disease model in rats

Research article

Increased first and second pulse harmonics in Tai Chi Chuan practitioners

Research article

In vitro antioxidant, anti-inflammatory and anticancer activities of ethyl acetate soluble proanthocyanidins of the inflorescence of Cocos nucifera L.